EchoSolv AS vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EchoSolv AS is a clinical decision support tool focused on identifying patients at risk for severe aortic stenosis by analyzing echocardiogram measurements. In contrast, IM007 is an AI-powered platform for remote cardiac monitoring, aggregating data from various cardiac implantable electronic devices to streamline workflows and manage alerts. While both leverage AI in cardiology, EchoSolv AS targets diagnostic support for a specific condition, whereas IM007 specializes in ongoing patient management and monitoring of implanted devices.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis (sAS) with high accuracy and efficiency. IM007 is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from cardiac implantable electronic devices (CIEDs) to streamline workflows and manage alerts, and includes predictive AI for heart failure hospitalization risk.
EchoSolv AS uses measurement-based AI to analyze numerical measurements from echocardiograms, not images, to assess the probability of severe aortic stenosis. IM007 unifies data aggregation from all major cardiac implantable electronic devices (CIEDs) and also utilizes ECG data for its ILR ECG Analyzer.
EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration. IM007 offers EHR integration capabilities through a bidirectional API and an integration framework.
EchoSolv AS's AI provides consistent severe AS probability and guideline checks from measurements, offering second reader support to help prioritize studies for closer review and enabling faster clinical review. IM007's AI-driven alert management reduces false positives (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts) and includes SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.
EchoSolv AS is designed to support Cardiology and Cardiothoracic Surgery. IM007 is intended for Cardiology and Hospital Medicine.